Rich Rubino | CFO |
Vince Anido | Chairman and CEO |
Tom Mitro | President and COO |
John LaRocca | General Counsel |
Adnan Butt | Guggenheim Securities |
Annabel Samimy | Stifel |
Dewey Steadman | Canaccord |
Serge Belanger | Needham and Company |
Elemer Piros | Cantor |
Oren Livnat | H.C. Wainwright |
Good afternoon, ladies and gentlemen. Thank you for standing by and welcome to the Aerie Pharmaceuticals Fourth Quarter and Full Year 2017 Earnings Conference Call. At this time, all participants are in a listen-only mode. Later, we will conduct a question-and-answer session and instructions will follow at that time. Today's conference call will be recorded.